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Title NMR‑based metabolic 
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Rebecca Jennings7, Sarah Siner7, Stephane C. Paulus1,8 & Enitan D. Carrol1,2,3*
Sepsis, defined as life‑threatening organ dysfunction caused by infection is difficult to distinguish 
clinically from infection or post‑operative inflammation. We hypothesized that in a heterogeneous 
group of critically ill children, there would be different metabolic profiles between post‑operative 
inflammation, bacterial and viral infection and infection with or without organ dysfunction. 1D 1H 
nuclear magnetic resonance spectra were acquired in plasma samples from critically ill children. We 
included children with bacterial (n = 25) and viral infection (n = 30) and controls (n = 58) (elective cardiac 
surgery without infection). Principal component analysis was used for data exploration and partial 
least squares discriminant analysis models for the differences between groups. Area under receiver 
operating characteristic curve (AUC) values were used to evaluate the models. Univariate analysis 
demonstrated differences between controls and bacterial and viral infection. There was excellent 
discrimination between bacterial and control (AUC = 0.94), and viral and control (AUC = 0.83), with 
slightly more modest discrimination between bacterial and viral (AUC = 0.78). There was modest 
discrimination (AUC = 0.73) between sepsis with organ dysfunction and infection with no organ 
dysfunction. In critically ill children, NMR metabolomics differentiates well between those with a post‑
operative inflammation but no infection, and those with infection (bacterial and viral), and between 
sepsis and infection.
Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, is a 
medical  emergency1. Diagnosis of sepsis can be difficult in the early stages, with non-specific symptoms. The 
host response to sepsis is an inflammatory cascade, with over-activation of the immune system, which without 
urgent treatment can rapidly lead to death. Newer definitions of sepsis have been developed for  adults1, but not 
children, and older  definitions2 fail to adequately characterise clinical presentations of sepsis. There is significant 
biological and clinical heterogeneity in individual patients with a clinical diagnosis of “sepsis”.
There are several hundred biomarkers of infection that have been studied, but none has been established as a 
sensitive and specific test for the diagnosis of sepsis. Blood cultures take 24–36 h for initial results, but polymerase 
chain reaction (PCR) of blood or cerebrospinal fluid (CSF) can diagnose infection more rapidly than standard 
culture techniques. Ascertainment of bacterial aetiology is based on detection by culture, PCR or antigen in a 
sterile site, such as blood, cerebrospinal fluid, urine or intra-operative specimens. Viral aetiology is ascertained 
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by viral PCR of respiratory specimens, blood, urine, CSF or other sterile site fluid. These microbiological inves-
tigations is may be augmented by laboratory tests (biochemical and haematological) and imaging studies such 
as chest X-ray, CT or MRI scan.
Molecular signatures from transcriptomic, metabolomic or proteomic analysis could potentially lead to more 
rapid diagnosis and better characterization of specific sub-populations subsets for targeted therapies. Metabo-
lomics has been applied to blood samples of patients with sepsis to attempt to determine the disease  severity3,4, 
or patient  outcome5–7. Sepsis results in alterations in concentrations of chemicals and small molecules in the 
blood, which can be measured and compared between different phenotypes or subtypes of sepsis, and in patients 
with different outcomes.
In this study we aimed to determine if, in critically ill children, plasma metabolomic profiling could dis-
tinguish between (a) infection versus post-operative inflammation without infection, (b) bacterial versus viral 
aetiology, (c) sepsis (infection with organ dysfunction) versus infection without organ dysfunction.
Results
Patient cohorts. Consecutive children admitted to a large tertiary centre paediatric intensive care unit 
(PICU), were recruited and categorised into those with bacterial or viral infection and controls (post-operative 
cardiac surgery with no infection). Characteristics of the cohort are summarised in Table 1 and Supplementary 
Fig. S1. Inclusion criteria from the patient cohort were children aged birth to 16 years, consecutively admitted to 
PICU between October 2010 and June 2012. Consecutive admissions were selected if there was sufficient plasma 
for metabolomic analysis, and if there was a clean phenotype of defined criteria. The groups were as closely age 
and sex matched as possible.
Diagnoses were defined according to Herberg et al.8 Control (C), (post-operative cardiac surgery patients with 
no infection), bacterial (definite bacterial (DB), children with culture or PCR-positive infection form a sterile 
site), viral (definite viral (DV), children with PCR, rapid antigen or immunofluorescent test-confirmed viral 
infection and no features or evidence of co-existing bacterial infections presenting with sepsis that was culture 
negative). Multiple organ dysfunction was defined as per Goldstein et al.2.
Optimisation of cohort criteria to produce clean phenotypes. Furthermore, post data acquisition 
an outlier detection algorithm identified two outliers in the control group and one viral outlier. Closer inspection 
of the spectra showed that one patient’s plasma had an extremely high level of citrate which may be indicative of 
sample collection in a non-approved plasma collection tube [plasma should be collected for nuclear magnetic 
resonance (NMR) metabolomics in heparin tubes as opposed to  citrate9,10. Outlier samples were removed from 
further analysis.
Metabolite identification. NMR spectra for all cohorts showed a consistent set of metabolite signals 
present with multiple metabolites annotated from 1D multiplet pattern overlap. NMR spectra of extracts were 
divided up into individual spectral bins accounting for one or more multiplets. The number of spectral bins in 
each sample were 144 of which 90 (62.5%) were assigned to 34 metabolites.
Correlations between different peaks assigned to the same metabolite were used in order to remove redundant 
peaks. Pairwise correlations were calculated for each metabolite that exhibited multiple peaks in NMR 1H spectra. 
The peaks that had correlations greater than 0.9 were removed leaving one representative peak. These included 
isoleucine, citrate, adipate and ornithine. Peaks that showed lower correlations were likely a product of peak 
overlaps in the spectra. As such a final decision could not be objectively made about the relative abundance of 
the metabolite and such peaks were left in as duplicates in order to not lose information. Therefore, duplicated 
metabolites should be interpreted as lower confidence signals.
Statistical analysis and differential abundance of metabolites between groups. Definite bac-
terial and definite viral versus control cohort. Statistical analysis of the two infected groups showed very dis-
Table 1.  Key characteristics of patient cohort. MODS multiple organ dysfunction patient count, LOS length of 
stay, PICU paediatric intensive care unit.
Bacterial infection (N = 25) Viral infection (N = 30) Controls (N = 58)
Age, median (range), months 28.4 (8.2–103.4) 9.3 (0.8–156.6) 16.2 (0.12–197.2)
Male, No. (%) 14 (56) 19 (63) 29 (50)
MODS, No. (%) 18 (72) 7 (23) 1 (1.7)
LOS on PICU, median (range), days 6.5 (0.5–26.6) 3.9 (1.7–45.6) 1.3 (0.57–29.4)
Deaths No 1 0 1
Pathogens
Klebsiella pneumoniae (2)









Herpes Simplex Virus (1)
Influenza A (3)
Respiratory Syncytial Virus (13)
Rhinovirus ( 9)
Varicella Zoster Virus ( 1)
(1 patient had more than 1 virus)
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tinct characteristics to the control population. Samples from each infected condition were compared to con-
trols first using a t test for each metabolite signal separately, followed by multivariate analysis using PCA and 
sPLSDA models. The results of the univariate analysis (Fig.  1) showed that the majority of differences were 
present between controls and infected groups. Around two-fold or higher increase over controls was observed 
for 3-hydroxybutyrate, lactate, phenylalanine, urea and valine and decrease in 2-hydroxyisobutyrate, isoleucine 
and pyruvate. Modest, but statistically significant increase in 2-hydroxyisovalerate, adipate, creatine phosphate, 
creatinine and isoleucine were also observed in the comparison of viral infections to controls while not present 
in the bacterial samples. In turn the bacterial samples showed decreased abundance of acetone, alanine and 
isobutyrate that was not observed in the viral cohort. Unsupervised analysis using PCA did not reveal substantial 
patterns in the data (Supplementary Figs. S2, S3) with only subtle differences between groups.
Discriminant analysis via sPLS-DA distinguished either viral or bacterial infection groups from the control 
population (Fig. 2a,b). In the process, contributing metabolites were identified (Fig. 2c,d). The area under the 
ROC curves (AUC) implied that the separation achieved by the models was good to excellent with AUC values 
of 0.84 between DV and C, and 0.93 between DB and C (Supplementary Figs. S5A,B, S6).
Amo0ng selected metabolites arginine, glucose, isoleucine and tyrosine were highly ranked in terms of con-
tribution in both models. In the model aimed to distinguish patients with bacterial infection from controls, 
myo-inositol, phenylalanine, lactate, pyruvate and 2-hydroxyisobutyrate were especially important. Conversely 
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Figure 1.  Metabolite abundance comparison. Each comparison is shown in column (C control, DV definite 
viral, DB definite bacterial). The numbers and colours denote log ratio of group means in statistically significant 
comparisons only (t-test, alpha = 0.05). Red means increased in DB:C or DV:C, purple lower in DB. DV relative 
to C or lower in DB relative to DV.
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Interestingly, most changes in metabolite abundance with respect to control patients are shared in both 
bacterial and viral infections (Supplementary Fig. S2). The fold changes of most measured metabolites point 
to similar changes in both infections with some notable exceptions including 2-hydroxyisovalerate, adipate, 
glutamine and histidine.
Bacterial versus viral infection. Similar analysis strategy was followed in the attempts to discriminate patients 
with bacterial and viral infection. The univariate tests showed a number of significant metabolite differences 
(albeit modest fold-changes) with all metabolites more abundant in samples from patients with viral infections 
(Fig. 1). These included 2-hydroxyisovalerate, alanine, citrate, creatine phosphate, creatinine, histidine, isoleu-
cine, ornithine and tyrosine (Supplementary Fig. S8).
While PCA did not reveal clear discrimination (Supplementary Fig. S7) the sPLS-DA model showed modest 
discrimination between the groups (AUC = 0.78, Supplementary Figs. S6, S9) that, although unlikely to be suffi-
cient for discriminant diagnoses, suggested biological pathways deviating between the two conditions via scrutiny 
of the metabolite differences. Metabolites ranked higher as discriminatory between samples from patients with 
bacterial and viral infections were isoleucine, urea, creatinine, 2-hydroxyisovalerate, tyrosine, valine, creatine 
phosphate and histidine among others (Fig. 3, Supplementary Fig. S8).
Metabolite association with organ dysfunction. Organ dysfunction occurs in a subset of patients with sepsis, 
and as such metabolic profiles have previously been associated with  dysfunction4. Plasma short- and medium-
chain acylcarnitines are associated with sepsis-related hepatobiliary and renal dysfunction, and might be mark-
ers of metabolic perturbation in liver and kidney. Acetylcarnitine is associated with organ dysfunction, systemic 
inflammation, and prognosis in  sepsis4.
Metabolite profiles were assessed with respect to multiple organ dysfunction (MOD), and it is important 
to note that the prevalence of MOD differed between children with bacterial and viral infections. There were 
18 patients with MOD out of 25 (72%) in the cohort with bacterial infection and 7 out of 30 (23%) in the viral 
cohort. Metabolite profiles were again investigated by pairwise comparisons of cohorts with and without MOD 
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VIP scores (C − DV)d
Figure 2.  Sparse partial least squares discriminant analysis (a) scores plot of model including DB (N = 25) and 
C (N = 58); (b) scores plot of model including DV (30) and C (N = 58); the most contributing metabolite signals 
(VIP scores); (c) C and DB; (d) C and DV. Associated AUC = 0.94 in DB-C and 0.83 in DV-C. DB—definite 
bacterial, DV – definite viral, C control, VIP variable importance score.
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Both children with MOD and those without MOD show similar alterations when compared to the control 
cohort with a few notable differences (Fig. 4). 2-Hydroxyisovalerate, adipate, creatine phosphate, creatinine, histi-
dine, isoleucine and ornithine show mild increase in abundance compared to control in those without MOD that 
is not observed in samples from those with MOD, while leucine is lower in those without MOD. When compared 
to each other, both cohorts of patients with infection show lower levels of alanine, creatine phosphate, creatinine, 
glutamine and histidine in those with MOD. The differences are further illustrated in  Supplementary Fig. S12.
A sPLS-DA model showed modest discrimination between the MOD-positive and MOD-negative group 
(AUC = 0.73, Fig. 5, Supplementary Fig. S13). The most influential metabolites highlighted by the model were 
2-hydroxyisovalerate, ornithine, isoleucine, creatinine, creatine phosphate and citrate among others (Fig. 5). 
Notably all the metabolites were more abundant in the samples from MOD-negative patients.
Biological contextualisation. Previous studies on different patient cohorts (primarily in North America) have 
posited multiple sepsis associated metabolites (Table 2)6,11–19. This UK-based study which includes confirmed 
bacterial and viral infection concurs with some metabolite findings indicative of global consensus between pop-
ulations with infection. Other metabolites that were not reported previously may be due to smaller sample size, 
different cohorts (adults/children, bacteraemic/non-bacteraemic, bacterial/viral) or potentially confounding 
factors arising from variation between different populations (genetic, environmental, severity).
The correlations of biochemical test results present for majority of patients and selected metabolites are shown 
in Supplementary Table S1.
Of the metabolites listed in Table 2, only 8 were associated with infection in the Human Metabolome Data-
base (HMDB). These metabolites were 2-aminobutyrate, glutamate, phenylalanine, pyruvate, 3-hydroxybutyrate, 
tyrosine, urea, and dimethylamine (DMA).
Discussion
This study demonstrates that several metabolites can be used to distinguish between bacterial and viral infec-
tion in critically ill children. Metabolite abundance differs between bacterial, viral and control respectively with 
excellent discrimination between bacterial and control (AUC = 0.94) and good discrimination between viral 
and control (AUC = 0.83). There was modest discrimination between bacterial and viral (AUC = 0.78), which 
reflects the fact that many infections in children go unconfirmed, and there is no valid reference standard for 
studies of biomarkers in sepsis. Despite decades of research for a “gold standard” biomarker of invasive bacte-
rial infections, only few biomarkers have been translated into routine clinical practice, with C-reactive protein 
(CRP) and procalcitonin being the most frequently used. Although blood culture has been considered as the 
“gold standard”, the process takes at least 48 h to result and is limited by false negative results. Use of CRP is 
















































































































VIP scores (DV − DB)b
Figure 3.  PLS-DA (a) scores plot of model including DB (N = 25) and DV (N = 30) samples. (b) Most 
contributing metabolite signals (VIP scores). Associated AUC = 0.78.
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also demonstrated good discrimination between bacterial infection with organ dysfunction versus infection 
(bacterial or viral) without organ dysfunction.
A study of patients with septic shock who had NMR spectroscopy-based metabolomics profiling, reported 
increased concentrations of phenylalanine, myo-inositol, isobutyrate, 3-hydroxybutyrate, urea, O-acetylcarnitine, 
2-hydroxybutyrate and proline, and decreased concentrations of propylene glycol, threonine, valine, arginine, 
glutamate, methanol and  glucose6. This supports our findings of increased phenylalanine, 2-hydroxybutyrate 
and 3-hydroxybutyrate in bacterial infection. However, in our study, valine, arginine, methanol and glucose were 
increased in bacterial and viral infection compared to controls, and glutamate was decreased. Most of our patients 
did not have septic shock, which explains this difference. In a study examining patients with septic shock in 
intensive care, six metabolites were identified as differentiating between survivors and non-survivors. Carnitine 
and citrulline were decreased in septic non-survivors, betaine, valine, leucine and isoleucine were increased in 
septic non-survivors18. In our study, we also demonstrated increased betaine, valine, leucine and isoleucine in 
bacterial infection compared to controls. The list of metabolites differentially abundant in MOD versus controls 
are also all present in the comparison between definite bacterial versus control and definite viral versus control. 
There were 5 metabolites which were had lower levels in those with MOD compared to those without; histidine, 
glutamine, creatinine, creatine phosphate, alanine. In patients with sepsis, increasing phosphoserine concentra-
tions were associated with higher severity of illness, kidney and liver dysfunction and death, and correlated with 
increasing cystathionine, 3-methylhistidine, histidine, hydroxyproline and  tyrosine21. Another study of patients 
with septic shock, phosphatidylcholines, lysophosphatidylcholines, acylcarnitines, and sphingomyelins were 
decreased in non-survivors, while kynurenine and polyunsaturated diacyl-phosphatidylcholines were increased. 
In non-survivors, glucogenic amino acids, putrescine and spermidine, were also increased. Phosphatidylcho-
lines, lysophosphatidylcholines were also lower in patients with renal  dysfunction22. In our study, with limited 





























































































































































log2 ratio of means
Figure 4.  Comparison of metabolic profiles for MOD, no MOD and control cohorts. (a) Metabolite abundance 
comparison. Each comparison is shown in column (C—control, Yes—multiple organ dysfunction, No—
no multiple organ dysfunction). The numbers and colours denote log ratio of group means in statistically 
significant comparisons only (t test, alpha = 0.05). Mean log ratios of MOD-positive and MOD negative group 
metabolic profiles with controls.
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not also use a mass spectrometry (MS) based technology like liquid-chromatography coupled mass spectrometry 
(LC–MS).
The 6 metabolites with the strongest ability to separate bacteraemic sepsis in the Emergency Department 
(ED) from those without sepsis were myristic acid, citric acid, isoleucine, norleucine, pyruvic acid and a 
 phosphocholine23. Decreased levels of isoleucine and norleucine in bacteraemic patients is consistent with our 
findings of lower leucine and isoleucine in definite bacterial group compared to  controls23. We demonstrated 
increased lactate in cases compared to controls.
One possible reason for the discrepancy in results between our study and previous studies, could relate to 
the timing of sampling. Metabolite profiles differ depending on timing of sampling. The samples in this study 
were taken on admission to PICU, but as the timing of onset of sepsis is unknown and there are varying lengths 
of time between first presentation to the ED and admission to PICU, this can result in variations in metabolic 
response  profiles13. Most previous studies have compared sepsis with systemic inflammatory response syndrome 
or controls, or bacterial with viral, but in this study, we have compared patients with infection and MOD to those 
with infection without MOD. Furthermore, this study has considered the influence of MOD upon investigation 
of these differences no observable effects were found (Supplementary Figs. S11, S12). Of the list of metabolites 
associated with sepsis or bacterial infection, only 8 of them were associated with infection in the HMDB data-
base. This reflects how little information on sepsis is included in the HMDB database. Studies such as ours are 
important in contributing to the publicly available data, which us why we have deposited the data to the EMBL-
EBI MetaboLights database (acc. num. MTBLS563).
Our study has several strengths; we compared bacterial versus viral, as well as bacterial versus controls and 
viral versus controls. Our control group consisted of children admitted to critical care without infection, these 
children were post-operative cardiac patients who were likely to have metabolite derangements as a result of 
surgery and intensive care management, therefore represents a good control group. Additionally, we examined 
metabolite changes with organ dysfunction, which is now a key component of the new sepsis  definition1. Previ-
ous studies, including our  own24 have failed to show significant differences in single biomarkers between post-
operative cardiac surgery patients with and without infection, and this study demonstrates that metabolic profiles 
are different between these groups. Limitations of our study include the fact that the number of patients with 
definite bacterial infection was low, and those with sepsis (infection with organ dysfunction) was even lower. 
This may explain why some findings from studies exclusively on children with sepsis were not replicated. Other 
limitations are that it is a single centre study, and there was no validation cohort, and therefore similar studies 
in different settings are required to determine generalisability.
Our study provides important new insights into the metabolic derangements associated with infection and 
organ dysfunction. The sepsis-3 definitions, developed for adult patients, have included organ dysfunction and 
infection for a diagnosis of sepsis, but these definitions may need to be modified for  children1. Our data sug-










































































Figure 5.  Metabolite profiles were investigated by pairwise comparisons of cohorts with and without MOD 
and fitting a PLS-DA model for selection of discriminating metabolites. The results show (a) scores plot (1 
component) of model including MOD positive patients with infection (blue) (N = 25) vs MOD negative patients 
with infection (red) (N = 30). (b) Metabolite importance (VIP) plot. Associated AUC = 0.73.
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with infection and no organ dysfunction. Recent studies have identified different phenotypes of adult sepsis 
based on host-response and organ  dysfunction25, and in paediatric sepsis, phenotypes in whom fluid bolus with 
unbuffered electrolyte solutions may be  harmful26. Defining accurate phenotypes within the clinical definition 
of “sepsis” has important implications for directing the optimal management strategy for each phenotype, in 
order to ensure the best outcomes.
In this well characterised cohort of critically ill children, metabolomic profiling demonstrated good discrimi-
nation between infection and post-operative inflammation, and between sepsis (bacterial infection with organ 
dysfunction) and infection without organ dysfunction.
Table 2.  Metabolites reported in the literature in published studies on infection and sepsis, that were also 
differentially increased or decreased in our cohort. Metabolites levels increase or decrease with sepsis/infection 
as indicated by + or –, respectively. Metabolites associated with sepsis/infection but levels not specified (or 
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acid 01873 *  + –
l-Isoleucine 00172 * * * *
l-Lactic 
acid 00190 * *  + *  + –
l-Leucine 00687 * * –
l-Lysine 00182 *  + 
Malic acid 00744 *
D-Mannose 00169 –
Methanol 01875 * –
l-Methio-
nine 00696 * *
myo-Ino-
sitol 00211 *  + 
O-Acetyl-
carnitine 00201 *  + 
Acetylcho-
line 00895  + *
Ornithine 00214 * *  + 
l-Phenyla-
lanine 00159 *  + *  + 
Phosphoryl-
choline 01565 *
l-Proline 00162  + * *
Propylene 
glycol 01881 - -
Pyroglu-
tamic acid 00267 *
Pyruvic acid 00243 * -
l-Serine 00187 *
Suberic acid 00893 *
Succinic 
acid 00254 *
Taurine 00251 *  +  + 
l-Threonine 00167 * - *
l-Tyrosine 00158 * *  + 
Urea 00294 *  + 
l-Valine 00883 - * *  + 
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Methods
Participants. Children from birth to 16 years admitted to the PICU between October 2010 and June 2012 
were eligible for inclusion. Pre-term infants < 37 weeks corrected gestation, children predicted not to survive 
at least 28 days due to a pre-existing condition or with an existing directive to withhold life-sustaining treat-
ment, children with end stage renal disease requiring chronic dialysis, end-stage liver disease, children admitted 
moribund and not expected to survive more than 24 h and non-intubated elective admissions with a predicted 
duration of stay less than 24 h were excluded from the study (Supplementary Fig. S1).
All methods were carried out in accordance with relevant guidelines and regulations. Written informed 
consent for participation in the study was obtained from parents or guardians. Children were followed up until 
day 28 after admission. The study was approved by the local research ethics committee (REC reference number: 
10/H1014/52-NRES Committee North West).
Sample collection. Blood samples were taken on admission to PICU in lithium heparin tubes (Sarsedt, 
Numbrecht Germany) at the same time as routine investigations. Samples were then frozen at – 80 °C within 2 h 
of collection and stored at – 80 °C until NMR analysis. Parameters of routine haematological and biochemical 
tests taken on admission, were also recorded (full blood count, renal function, liver function, coagulation and 
C-reactive protein).
Sample groups. Sample groups for the purpose of determining a clean phenotype were defined as infants 
and children older than 4  weeks with an age range of 4  weeks–14.33  years of age (0.08–14.33). All eligible 
patients as defined by the sample group criteria were selected for the bacterial and viral infection groups. To 
reduce effect of age and gender the control group samples were selected to match as closely as possible with 
gender split in the sample groups between 36 and 50% (Table 1).
Patients were assigned to diagnostic groups using predefined criteria as per  Herberg8. The following defini-
tions were used:
• Definite bacterial infection: children with culture or PCR-confirmed infection from a sterile site
• Definite viral infection: children with PCR or immunofluorescent test–confirmed viral infection and no 
features of co-existing bacterial infection
• Sepsis: life-threatening organ dysfunction caused by a dysregulated host response to  infection1. Organ dys-
function was defined according to Goldstein 2005 and Multiple Organ Dysfunction (MOD) defined as or 
two or more organ dysfunctions (respiratory, renal, neurologic, hematologic, or hepatic)2.
• Controls: post-operative cardiac surgery patients admitted electively to critical care, in whom no infection 
was diagnosed. These patients have previously been described, and had evidence of post-operative inflam-
mation with raised Procalcitonin and C-reactive protein on post-operative day 2 and  324.
Sample preparation for NMR. 100ul of serum was thawed on ice before addition of buffer to create a 
final sample composition of 100 mM sodium phosphate pH 7.40, 0.02% (w/v) sodium azide to a final volume 
of 200 μl containing 10% 2H2O. The sample was vortexed for 30 s and then centrifuged (21,500g, 4 °C, 5 min). 
180 μl of supernatant was then transferred to a 3 mm outer diameter NMR tube using a glass Pasteur with care 
taken not to disturb any pelleted material.
NMR setup acquisition and processing. 1D 1H NMR spectra were acquired on a Bruker Avance III 
HD 700 spectrometer equipped with a 5 mm TCI cryoprobe and SampleJet autosampler. Spectra acquired at 
pH 7.4 and 37 °C using standard vendors pulse sequence with the cpmgpr1d using Carr-Purcell-Meiboom-Gill 
(CPMG) filters for selective observation of low molecular weight components with optimal water suppression 
were acquired. Spectra were acquired with 32 transients a 20 ppm spectral width, 64 K points, 9.6 ms echo time 
and a 3.1 s acquisition time and a 4 s interscan delay.
Spectra processing and quality control. Automated data processing, Fourier transformation, and 
phasing were performed in Topspin v3.2 (Topspin 3.2.pl7 https ://www.bruke r.com/produ cts/mr/nmr/softw are/
topsp in.html) software using standard Bruker routines. The spectra were referenced indirectly to TSP via the 
anomeric glucose doublet at 5.204 ppm and then normalised to via probabilistic quotient  normalisation27. The 
spectra were then bucketed per peak into a matrix of metabolite peak intensities using custom R scripts.
Metabolite annotation and identification. Chenomx v 8.2 (Chenomx 8.2 https ://www.cheno mx.com/) 
software was used for initial metabolite annotation followed by manual confirmation of identities using in-house 
standards for metabolite peaks. Identification and annotation levels are reported in the deposited data according 
to Metabolomics standards initiative  guidelines28–31. Raw data, experimental parameters, annotations and iden-
tities are deposited in the open source repository Metabolights hosted by the European Bioinformatics Institute 
(EBI)32 accession number MTBLS563.
Statistical analysis. Multivariate statistical analysis was performed using R statistical computing envi-
ronment [r-project.org]33. Data was first normalized using probabilistic quotient normalisation to account for 
potential dilution effects in the samples. Principal component analysis (PCA) was then used for data exploration. 
An automatic outlier detection, based on Mahalanobis distance of samples in the PCA within each group, was 
performed. In short, the method relied on calculation of Mahalanobis distance to the centroid of each group of 
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samples in the PC space taking the number of principal components that accounted for at least 95% of the vari-
ance. A distance cut-off was then calculated as a 99th percentile of the Chi-squared distribution with degrees of 
freedom set to the chosen number of principal components. Points further from the centroid than the cut-off 
distance were flagged as outliers. Three samples were removed from the data as outliers. The samples were split 
into three groups based on the criteria described by  Herberg8—control, definite bacterial infection, definite viral 
infection. The samples from patients with unknown or unclear diagnosis were excluded from the analysis. The 
relative metabolite concentrations were compared between groups using a Student’s t test with p value correction 
for multiple comparisons using Benjamini–Hochberg method.
In order to assess the differences between diagnosis groups sparse partial least squares discriminant analysis 
(sPLS-DA) models were built. PLS-DA is a multivariate method that finds a low-dimensional representation 
of data maximising the correlation with the grouping (e.g. diagnosis classes). Sparse PLS-DA includes implicit 
variable selection based on Lasso  regression34 which allows automated selection of most contributing variables. 
In order to avoid overfitting fivefold cross-validation was used for selecting the number of PLS-DA components. 
Models were assessed using receiver operating characteristic (ROC) curves using a hold-out dataset that was 
not used in the fitting of the models. Hold out datasets used for each model comprised of randomly selected 
subset of 30% of the patients, keeping the proportions of the groups (control-bacterial, control-viral etc.) similar 
to remaining 70%. Models were then fit to the remaining 70% of the data and tested on the hold out dataset to 
assess the model performance without bias. ROC curves were calculated from the predicted values. sPLS-DA 
scores plots as well as ROC curves and area under ROC curve (AUROC) values were assessed in order to evaluate 
the models. The modelling was performed using  MixOmics35 package in R statistical computing environment.
Ethics. Written informed consent for participation in the study was obtained from parents or guardians. 
Children were followed up until day 28 after admission. The study was approved by the local research ethics 
committee (REC reference number: 10/H1014/52).
Data availability
Raw data, experimental parameters, annotations and identities are deposited in the open source repository 
Metabolights hosted by the European Bioinformatics Institute (EBI)32 accession number MTBLS563.
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